PL348831A1 - Improvements in or relating to powders - Google Patents

Improvements in or relating to powders

Info

Publication number
PL348831A1
PL348831A1 PL34883199A PL34883199A PL348831A1 PL 348831 A1 PL348831 A1 PL 348831A1 PL 34883199 A PL34883199 A PL 34883199A PL 34883199 A PL34883199 A PL 34883199A PL 348831 A1 PL348831 A1 PL 348831A1
Authority
PL
Poland
Prior art keywords
powders
relating
improvements
Prior art date
Application number
PL34883199A
Inventor
David Ganderton
David Alexander Vodden Morton
Paul Lucas
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9827145A priority Critical patent/GB9827145D0/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority to PCT/GB1999/004156 priority patent/WO2000033811A2/en
Publication of PL348831A1 publication Critical patent/PL348831A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
PL34883199A 1998-12-09 1999-12-09 Improvements in or relating to powders PL348831A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9827145A GB9827145D0 (en) 1998-12-09 1998-12-09 Improvements in or relating to powders
PCT/GB1999/004156 WO2000033811A2 (en) 1998-12-09 1999-12-09 Improvements in or relating to powders

Publications (1)

Publication Number Publication Date
PL348831A1 true PL348831A1 (en) 2002-06-17

Family

ID=10843948

Family Applications (1)

Application Number Title Priority Date Filing Date
PL34883199A PL348831A1 (en) 1998-12-09 1999-12-09 Improvements in or relating to powders

Country Status (23)

Country Link
US (1) US6989155B1 (en)
EP (1) EP1137399B1 (en)
JP (1) JP4410942B2 (en)
CN (1) CN1334723A (en)
AT (1) AT240093T (en)
AU (1) AU770461B2 (en)
BR (1) BR9916102A (en)
CA (1) CA2353448C (en)
CZ (1) CZ20012043A3 (en)
DE (1) DE69907951T2 (en)
DK (1) DK1137399T3 (en)
EA (1) EA004045B1 (en)
ES (1) ES2198973T3 (en)
GB (1) GB9827145D0 (en)
HU (1) HU0104513A3 (en)
MX (1) MXPA01005584A (en)
NO (1) NO20012825L (en)
NZ (1) NZ511965A (en)
PL (1) PL348831A1 (en)
PT (1) PT1137399E (en)
SK (1) SK284775B6 (en)
TR (1) TR200101591T2 (en)
WO (1) WO2000033811A2 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US9006175B2 (en) * 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2569949T3 (en) 1999-06-29 2016-05-13 Mannkind Corporation pharmaceutical formulations comprising a peptide complexed with a diketopiperazine
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
JP2001151673A (en) * 1999-09-06 2001-06-05 Nikken Chem Co Ltd Production of powdery preparation for inhalation
NZ526059A (en) 2000-11-30 2005-05-27 Vectura Ltd Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition
EP3269360A1 (en) 2000-11-30 2018-01-17 Vectura Limited Method of making particles for use in a pharmaceutical composition
EP1296651B2 (en) * 2000-06-27 2019-07-17 Vectura Limited Method of making particles for use in a pharmaceutical composition
CA2413692C (en) * 2000-06-27 2011-10-18 Vectura Limited Method of making particles for use in a pharmaceutical composition
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US8580306B2 (en) 2000-11-30 2013-11-12 Vectura Limited Particles for use in a pharmaceutical composition
JP2005520843A (en) * 2002-03-20 2005-07-14 アドバンスト インハレーション リサーチ,インコーポレイテッド Sustained for respiratory therapeutic formulation
JP4681231B2 (en) 2002-03-20 2011-05-11 マンカインド コーポレイション Inhaler
US20110123574A1 (en) * 2002-03-20 2011-05-26 Alkermes, Inc. Inhalable sustained therapeutic formulations
CA2478327A1 (en) * 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Hgh (human growth hormone) formulations for pulmonary administration
US7754242B2 (en) 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
BRPI0409380A (en) * 2003-04-14 2006-04-18 Vectura Ltd Pharmaceutical compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
ES2385934T3 (en) 2004-08-20 2012-08-03 Mannkind Corporation Catalysis of the synthesis of dicetopiperazina.
DK2314298T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Microparticles comprising diketopiperazinsalte for drug delivery
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
MX2007009656A (en) 2005-02-10 2007-11-07 Glaxo Group Ltd Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom.
US8062670B2 (en) * 2005-08-05 2011-11-22 3M Innovative Properties Company Compositions exhibiting improved flowability
EP1928423B1 (en) 2005-09-14 2015-12-09 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
GB0525254D0 (en) * 2005-12-12 2006-01-18 Jagotec Ag Powder compositions for inhalation
CN104383546A (en) * 2006-02-22 2015-03-04 曼金德公司 Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
DE102006030164A1 (en) * 2006-06-29 2008-01-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative powders
DE102006053375A1 (en) 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for mixing powders
US20090048155A1 (en) 2007-08-15 2009-02-19 Endacea, Inc. Methods for preventing and treating tissue injury and sepsis associated with Yersinia pestis infection
US8785396B2 (en) * 2007-10-24 2014-07-22 Mannkind Corporation Method and composition for treating migraines
JP5603248B2 (en) 2007-12-21 2014-10-08 エンダセア, インコーポレイテッド A1 adenosine receptor antagonist
SG10201507038VA (en) 2008-06-13 2015-10-29 Mannkind Corp A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
TWI532497B (en) 2008-08-11 2016-05-11 曼凱公司 Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2405963T3 (en) 2009-03-11 2014-04-30 Mannkind Corp Apparatus, system and method for measuring resistance of an inhaler
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
WO2011094208A2 (en) 2010-01-26 2011-08-04 Endacea, Inc. Methods and pharmaceutical compositions for preventing and treating renal impairment
BR112012033060A2 (en) 2010-06-21 2018-02-27 Mannkind Corp Dry powder drug release system methods
WO2012030647A1 (en) * 2010-08-30 2012-03-08 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
KR20180122475A (en) 2010-09-29 2018-11-12 풀매트릭스 오퍼레이팅 컴퍼니, 인크 Monovalent metal cation dry powders for inhalation
CN107854454A (en) * 2010-11-09 2018-03-30 曼金德公司 For treating the composition comprising serotonin receptor agonist and diketopiperazine of antimigraine
AU2015249177B2 (en) * 2010-11-09 2017-08-03 Mannkind Corporation Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
RU2448717C1 (en) * 2011-04-20 2012-04-27 Закрытое акционерное общество Научно-производственное предприятие "Тринита" Method for making anticoagulant-fibrinolytic heparin preparation
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP2776053A1 (en) 2011-10-24 2014-09-17 MannKind Corporation Methods and compositions for treating pain
RU2650035C2 (en) 2012-07-12 2018-04-06 Маннкайнд Корпорейшн Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
WO2014106727A1 (en) 2013-01-03 2014-07-10 Vectura Limited Inhaler and formulation
BR112015023168A2 (en) 2013-03-15 2017-07-18 Mannkind Corp microcrystalline diketopiperazine compositions and methods
KR20150135328A (en) 2013-04-01 2015-12-02 풀매트릭스 인코퍼레이티드 Tiotropium dry powders
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US20190177588A1 (en) * 2017-12-12 2019-06-13 Xotramorphic LLC Compositions, Methods, and Systems For Producing Flocculent Materials for Special Effects

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
JP3708553B2 (en) * 1995-04-14 2005-10-19 ネクター セラピューティクス Powder form pharmaceutical compositions having improved dispersibility
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
ES2343124T3 (en) * 1999-10-29 2010-07-23 Novartis Ag Dry powder compositions with improved dispersability.

Also Published As

Publication number Publication date
JP4410942B2 (en) 2010-02-10
GB9827145D0 (en) 1999-02-03
US6989155B1 (en) 2006-01-24
NO20012825L (en) 2001-06-08
MXPA01005584A (en) 2003-07-14
JP2002531487A (en) 2002-09-24
DK1137399T3 (en) 2003-08-18
PT1137399E (en) 2003-09-30
AU770461B2 (en) 2004-02-19
AT240093T (en) 2003-05-15
SK284775B6 (en) 2005-11-03
WO2000033811A3 (en) 2000-10-12
HU0104513A3 (en) 2003-12-29
EA200100636A1 (en) 2001-12-24
DE69907951D1 (en) 2003-06-18
ES2198973T3 (en) 2004-02-01
EP1137399B1 (en) 2003-05-14
TR200101591T2 (en) 2001-11-21
CN1334723A (en) 2002-02-06
BR9916102A (en) 2001-09-04
DE69907951T2 (en) 2004-03-11
EA004045B1 (en) 2003-12-25
EP1137399A2 (en) 2001-10-04
WO2000033811A2 (en) 2000-06-15
HU0104513A2 (en) 2002-03-28
CA2353448A1 (en) 2000-06-15
AU1577700A (en) 2000-06-26
NZ511965A (en) 2003-09-26
NO20012825D0 (en) 2001-06-08
CA2353448C (en) 2010-02-23
CZ20012043A3 (en) 2001-12-12
SK7772001A3 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
GB2355335B (en) Improvements in or relating to cables
GB2327074B (en) Improvements in or relating to capsules
GB2350813B (en) Improvements in or relating to knives
GB2344792B (en) Improvements in or relating to an air-bag arrangement
GB2327066B (en) Improvements in or relating to an air-bag
PL344863A1 (en) Improved in vivo
DE69927412D1 (en) Phosphitadditive in polyolefinen
GB9726664D0 (en) Improvements in or relating to ultrasonography
IL125748D0 (en) Improvements in or relating to contrast agents
HU0000282A3 (en) Improvements in or relating to contrast agents
GB2355200B (en) Improvements in or relating to devices
GB9822963D0 (en) Improvements in or relating to chromatography
GB9827779D0 (en) Improvements in or relating to appliances
MX9807863A (en) Improvements in or relating to encapsulation
GB2321004B (en) Improvements in or relating to enclosures
GB9807977D0 (en) Improvements in or relating to coating
GB2335545B (en) Improvements in or relating to enclosures
GB9618635D0 (en) Improvements in or relating to sensors
HU0102897A3 (en) Improvements in or relating to packaging
GB2357465B (en) Improvements in or relating to an air-bag
GB9930728D0 (en) Improvements in or relating to aircraft
GB9624352D0 (en) Improvements in or relating to packaging
GB9720108D0 (en) Improvements in Magnotherapy
GB9818098D0 (en) Improvements in or relating to bearings
MXPA01005584A (en) Improvements in or relating to powders.

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patents lapsed